Your browser doesn't support javascript.
loading
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Neumann, Alexander; Küçükali, Fahri; Bos, Isabelle; Vos, Stephanie J B; Engelborghs, Sebastiaan; De Pooter, Tim; Joris, Geert; De Rijk, Peter; De Roeck, Ellen; Tsolaki, Magda; Verhey, Frans; Martinez-Lage, Pablo; Tainta, Mikel; Frisoni, Giovanni; Blin, Oliver; Richardson, Jill; Bordet, Régis; Scheltens, Philip; Popp, Julius; Peyratout, Gwendoline; Johannsen, Peter; Frölich, Lutz; Vandenberghe, Rik; Freund-Levi, Yvonne; Streffer, Johannes; Lovestone, Simon; Legido-Quigley, Cristina; Ten Kate, Mara; Barkhof, Frederik; Strazisar, Mojca; Zetterberg, Henrik; Bertram, Lars; Visser, Pieter Jelle; van Broeckhoven, Christine; Sleegers, Kristel.
Afiliação
  • Neumann A; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium. alexander.neumann@uantwerpen.vib.be.
  • Küçükali F; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. alexander.neumann@uantwerpen.vib.be.
  • Bos I; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Vos SJB; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Engelborghs S; Netherlands Institute for Health Services Research, Utrecht, the Netherlands.
  • De Pooter T; Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
  • Joris G; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • De Rijk P; Department of Neurology and Memory Clinic, Universitair Ziekenhuis Brussel (UZ Brussel) and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
  • De Roeck E; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Tsolaki M; Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Verhey F; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Martinez-Lage P; Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Tainta M; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Frisoni G; Neuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Blin O; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Richardson J; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium.
  • Bordet R; 1st Department of Neurology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Makedonia, Thessaloniki, Greece.
  • Scheltens P; Alzheimer Centrum Limburg, Maastricht University, Maastricht, the Netherlands.
  • Popp J; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
  • Peyratout G; School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Johannsen P; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.
  • Frölich L; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.
  • Vandenberghe R; Department of Psychiatry, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Freund-Levi Y; RCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Streffer J; Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital, Marseille, France.
  • Lovestone S; Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevanage, UK.
  • Legido-Quigley C; Neuroscience & Cognition, CHU de Lille, University of Lille, Inserm, France.
  • Ten Kate M; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands.
  • Barkhof F; Department of Geriatric Psychiatry, University Hospital of Psychiatry Zürich, Zürich, Switzerland.
  • Strazisar M; Old Age Psychiatry, Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
  • Zetterberg H; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
  • Bertram L; Clinical Drug Development, Novo Nordisk, Copenhagen, Denmark.
  • Visser PJ; Department of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • van Broeckhoven C; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
  • Sleegers K; Center for Alzheimer Research, Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society Karolinska Institute Stockholm Sweden, Stockholm, Sweden.
Mol Psychiatry ; 27(4): 1990-1999, 2022 04.
Article em En | MEDLINE | ID: mdl-35173266
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica